A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
Hanjun Zhao(Hebei Medical University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Hin Chu(University of Hong Kong), Hoiyan Lam(Department of Health), Kong‐Hung Sze(University of Hong Kong), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Man Lung Yeung(Hong Kong Science and Technology Parks Corporation), Cun Li(Xinjiang Medical University), Mingjie Bian(Anhui Normal University), Timothy Tin-Mong Yung(Department of Health)
Cited by 115
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k